ECIM 2025 saw a heated discussion on whether anticoagulation in DVT should be treated like a chronic condition, as new ...

There is an apparent underuse of warfarin in elderly patients with AF, as there is inconsistency in opinion among clinicians about who should receive anticoagulation. The risks of warfarin are ...

Even with recommendations in place, hospitals were far from uniform in their anticoagulation approaches well into 2022.

The following is a summary of “Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: ...

In reconstructive surgery, specifically free flap reconstructive surgery, concerns persist regarding the risk of failures due ...

Opens in a new tab or window A population-based cohort study found an association between bleeding events in Afib patients on oral anticoagulation and cancer diagnoses. In cases where cancer was ...

"Appropriate investigations for a source of bleeding may also increase confidence in resuming anticoagulation if the underlying cause is addressed, or no serious pathology is uncovered." ...

PERIXa protocol shows minimal bleeding risk in AF patients, ensuring safe anticoagulation management for minor procedures.

Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company focused on the development of specialized ...

Promising results show that abelacimab could revolutionize anticoagulation therapy by slashing bleeding risks without compromising stroke protection for patients with atrial fibrillation.

In this randomized controlled trial, among patients with atrial fibrillation requiring anticoagulation therapy, asundexian ...